Maureen Menwa Achebe, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Sickle Cell | 17 | 2021 | 1018 | 2.570 |
Why?
|
Anemia, Iron-Deficiency | 10 | 2023 | 365 | 1.640 |
Why?
|
Hematinics | 4 | 2020 | 281 | 1.560 |
Why?
|
Ferric Compounds | 7 | 2022 | 374 | 1.360 |
Why?
|
Antisickling Agents | 4 | 2019 | 80 | 0.920 |
Why?
|
Hydroxyurea | 5 | 2019 | 290 | 0.880 |
Why?
|
Disaccharides | 5 | 2022 | 171 | 0.830 |
Why?
|
Pregnancy Complications, Hematologic | 3 | 2017 | 183 | 0.800 |
Why?
|
Death, Sudden | 1 | 2019 | 302 | 0.610 |
Why?
|
Iron | 4 | 2023 | 1774 | 0.600 |
Why?
|
Glucaric Acid | 2 | 2017 | 10 | 0.590 |
Why?
|
Leukocyte Count | 1 | 2021 | 1588 | 0.580 |
Why?
|
Hemoglobins | 8 | 2022 | 1534 | 0.520 |
Why?
|
Vitamin B Complex | 1 | 2016 | 288 | 0.490 |
Why?
|
Vitamin B 12 | 1 | 2016 | 527 | 0.460 |
Why?
|
Hemoglobin, Sickle | 4 | 2021 | 122 | 0.460 |
Why?
|
Maltose | 2 | 2020 | 34 | 0.450 |
Why?
|
Iron-Dextran Complex | 1 | 2012 | 14 | 0.440 |
Why?
|
Adenosine A2 Receptor Agonists | 2 | 2013 | 27 | 0.430 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 884 | 0.400 |
Why?
|
Anemia | 2 | 2016 | 1506 | 0.390 |
Why?
|
Pyrazoles | 4 | 2021 | 1972 | 0.380 |
Why?
|
Benzaldehydes | 2 | 2021 | 58 | 0.370 |
Why?
|
Folic Acid | 1 | 2016 | 1300 | 0.360 |
Why?
|
Natural Killer T-Cells | 2 | 2013 | 316 | 0.340 |
Why?
|
Fetal Hemoglobin | 2 | 2020 | 341 | 0.330 |
Why?
|
Purines | 2 | 2013 | 594 | 0.330 |
Why?
|
Sickle Cell Trait | 2 | 2019 | 81 | 0.330 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2015 | 789 | 0.320 |
Why?
|
Neutrophils | 1 | 2021 | 3719 | 0.320 |
Why?
|
Drug Approval | 1 | 2014 | 742 | 0.310 |
Why?
|
Ferrous Compounds | 1 | 2017 | 42 | 0.300 |
Why?
|
Patient Readmission | 1 | 2020 | 3114 | 0.270 |
Why?
|
Ferritins | 1 | 2017 | 590 | 0.240 |
Why?
|
Pyrazines | 2 | 2021 | 1230 | 0.240 |
Why?
|
Hypophosphatemia | 2 | 2022 | 85 | 0.220 |
Why?
|
Receptor, Adenosine A2A | 1 | 2013 | 124 | 0.210 |
Why?
|
Hydroxamic Acids | 1 | 2015 | 494 | 0.210 |
Why?
|
Administration, Oral | 2 | 2017 | 3913 | 0.210 |
Why?
|
Endothelium-Dependent Relaxing Factors | 1 | 2011 | 19 | 0.200 |
Why?
|
IgA Deficiency | 1 | 2011 | 43 | 0.200 |
Why?
|
Thymus Hyperplasia | 1 | 2011 | 30 | 0.190 |
Why?
|
Duffy Blood-Group System | 1 | 2021 | 58 | 0.190 |
Why?
|
gamma-Globins | 1 | 2020 | 95 | 0.180 |
Why?
|
Ikaros Transcription Factor | 1 | 2011 | 217 | 0.180 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2011 | 223 | 0.160 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 724 | 0.160 |
Why?
|
Acute Chest Syndrome | 2 | 2020 | 31 | 0.150 |
Why?
|
Arterial Occlusive Diseases | 1 | 2021 | 793 | 0.150 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 102 | 0.140 |
Why?
|
Adult | 23 | 2022 | 214055 | 0.140 |
Why?
|
Folic Acid Deficiency | 1 | 2016 | 115 | 0.140 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2016 | 116 | 0.130 |
Why?
|
Anaphylaxis | 1 | 2023 | 746 | 0.130 |
Why?
|
Bone Marrow Diseases | 1 | 2017 | 231 | 0.130 |
Why?
|
Anemia, Aplastic | 1 | 2017 | 226 | 0.130 |
Why?
|
Glomerular Filtration Rate | 2 | 2019 | 2170 | 0.130 |
Why?
|
Albuminuria | 1 | 2018 | 682 | 0.120 |
Why?
|
Hospitalization | 1 | 2014 | 10262 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2013 | 1161 | 0.120 |
Why?
|
Length of Stay | 2 | 2020 | 6309 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 9959 | 0.120 |
Why?
|
Female | 25 | 2021 | 380194 | 0.110 |
Why?
|
Reference Values | 1 | 2021 | 4982 | 0.110 |
Why?
|
Humans | 35 | 2023 | 744343 | 0.110 |
Why?
|
Adolescent | 12 | 2021 | 85781 | 0.110 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2765 | 0.110 |
Why?
|
Phospholipases A2, Secretory | 1 | 2012 | 31 | 0.110 |
Why?
|
Nitric Oxide | 1 | 2011 | 2132 | 0.100 |
Why?
|
Erythrocyte Transfusion | 1 | 2016 | 565 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2133 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1518 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2889 | 0.100 |
Why?
|
Male | 21 | 2021 | 350118 | 0.100 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1420 | 0.090 |
Why?
|
Child, Preschool | 5 | 2020 | 41006 | 0.090 |
Why?
|
Multicenter Studies as Topic | 2 | 2022 | 1677 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2020 | 3023 | 0.090 |
Why?
|
Acute Disease | 1 | 2020 | 7149 | 0.080 |
Why?
|
Young Adult | 10 | 2021 | 56430 | 0.080 |
Why?
|
Child | 9 | 2021 | 77709 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6538 | 0.080 |
Why?
|
Middle Aged | 14 | 2021 | 213383 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2208 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2011 | 4665 | 0.080 |
Why?
|
Kidney Diseases | 1 | 2018 | 2149 | 0.080 |
Why?
|
Insurance, Health | 1 | 2020 | 2494 | 0.070 |
Why?
|
Infusions, Intravenous | 2 | 2013 | 2274 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2736 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2017 | 2795 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3022 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3209 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1584 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 18370 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2020 | 5317 | 0.070 |
Why?
|
United States | 6 | 2020 | 69872 | 0.070 |
Why?
|
Infant | 4 | 2020 | 35136 | 0.070 |
Why?
|
Pain | 1 | 2011 | 4986 | 0.070 |
Why?
|
Telemedicine | 1 | 2023 | 2872 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12354 | 0.060 |
Why?
|
Treatment Outcome | 8 | 2022 | 63114 | 0.060 |
Why?
|
Retrospective Studies | 4 | 2019 | 77449 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2021 | 10943 | 0.060 |
Why?
|
Pregnancy | 4 | 2018 | 29144 | 0.060 |
Why?
|
Time Factors | 3 | 2020 | 40075 | 0.060 |
Why?
|
Incidence | 4 | 2023 | 20947 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2861 | 0.050 |
Why?
|
Headache | 2 | 2021 | 1226 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2021 | 12026 | 0.050 |
Why?
|
Aged | 6 | 2021 | 163280 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39050 | 0.050 |
Why?
|
Hookworm Infections | 1 | 2011 | 13 | 0.050 |
Why?
|
Plasma Volume | 1 | 2011 | 36 | 0.050 |
Why?
|
Transcription Factor RelA | 1 | 2013 | 275 | 0.050 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2011 | 54 | 0.050 |
Why?
|
Fatigue | 1 | 2017 | 1531 | 0.040 |
Why?
|
Thymoma | 1 | 2011 | 186 | 0.040 |
Why?
|
Pneumothorax | 1 | 2003 | 379 | 0.040 |
Why?
|
P-Selectin | 1 | 2021 | 600 | 0.040 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2011 | 255 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.040 |
Why?
|
Polymerization | 1 | 2019 | 164 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2013 | 2327 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 72290 | 0.040 |
Why?
|
Thymus Neoplasms | 1 | 2011 | 268 | 0.040 |
Why?
|
Menorrhagia | 1 | 2018 | 63 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 426 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2011 | 1105 | 0.040 |
Why?
|
Lactation Disorders | 1 | 2017 | 16 | 0.040 |
Why?
|
Demography | 1 | 2023 | 1656 | 0.040 |
Why?
|
Cell Count | 1 | 2012 | 1856 | 0.040 |
Why?
|
Hemolysis | 1 | 2019 | 420 | 0.040 |
Why?
|
Placebo Effect | 1 | 2021 | 502 | 0.040 |
Why?
|
Nausea | 1 | 2020 | 673 | 0.040 |
Why?
|
Drug Dosage Calculations | 1 | 2017 | 114 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2017 | 588 | 0.030 |
Why?
|
Phosphates | 1 | 2020 | 786 | 0.030 |
Why?
|
Remission Induction | 1 | 2012 | 2386 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1655 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2124 | 0.030 |
Why?
|
Fetal Death | 1 | 2017 | 448 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2003 | 1381 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2309 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2017 | 3297 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2013 | 3206 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 3002 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15165 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.030 |
Why?
|
Registries | 2 | 2019 | 8089 | 0.030 |
Why?
|
Telomerase | 1 | 2017 | 730 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2013 | 5974 | 0.030 |
Why?
|
Abortion, Spontaneous | 1 | 2017 | 544 | 0.030 |
Why?
|
Bariatric Surgery | 1 | 2022 | 952 | 0.030 |
Why?
|
Quality of Life | 2 | 2018 | 12804 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2011 | 2540 | 0.030 |
Why?
|
Pre-Eclampsia | 1 | 2011 | 1200 | 0.030 |
Why?
|
Phosphorylation | 1 | 2013 | 8436 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3505 | 0.020 |
Why?
|
Infertility, Female | 1 | 2017 | 787 | 0.020 |
Why?
|
Pain Measurement | 1 | 2011 | 3420 | 0.020 |
Why?
|
Malaria | 1 | 2011 | 1239 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2020 | 3420 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6489 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 2957 | 0.020 |
Why?
|
Prognosis | 2 | 2013 | 29063 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2017 | 57776 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8324 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 40561 | 0.020 |
Why?
|
RNA | 1 | 2017 | 2749 | 0.020 |
Why?
|
Sepsis | 1 | 2011 | 2593 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 12951 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2011 | 14557 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 7913 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5137 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2013 | 21746 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8388 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5078 | 0.010 |
Why?
|
Animals | 2 | 2012 | 168757 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2003 | 13102 | 0.010 |
Why?
|
Signal Transduction | 1 | 2011 | 23403 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 25625 | 0.010 |
Why?
|
Mutation | 1 | 2011 | 29786 | 0.010 |
Why?
|
HIV Infections | 1 | 2011 | 16718 | 0.010 |
Why?
|
Mice | 1 | 2011 | 81183 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8340 | 0.010 |
Why?
|
Biopsy | 1 | 2003 | 6756 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12959 | 0.000 |
Why?
|